<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101671285</journal-id>
<journal-id journal-id-type="pubmed-jr-id">44575</journal-id>
<journal-id journal-id-type="nlm-ta">Biol Psychiatry Cogn Neurosci Neuroimaging</journal-id>
<journal-id journal-id-type="iso-abbrev">Biol Psychiatry Cogn Neurosci Neuroimaging</journal-id>
<journal-title-group>
<journal-title>Biological psychiatry. Cognitive neuroscience and neuroimaging</journal-title>
</journal-title-group>
<issn pub-type="epub">2451-9030</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29884282</article-id>
<article-id pub-id-type="pmc">5995132</article-id>
<article-id pub-id-type="doi">10.1016/j.bpsc.2017.12.011</article-id>
<article-id pub-id-type="manuscript">NIHMS943292</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Interoception and Inflammation in Psychiatric Disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Savitz</surname>
<given-names>Jonathan</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Harrison</surname>
<given-names>Neil A</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Laureate Institute for Brain Research, Tulsa OK, USA</aff>
<aff id="A2">
<label>2</label>Oxley College of Health Sciences, The University of Tulsa, Tulsa OK, USA</aff>
<aff id="A3">
<label>3</label>Department of Neuroscience, Brighton and Sussex Medical School, University of Sussex, Brighton, BN1 9RR, UK</aff>
<aff id="A4">
<label>4</label>Sackler Centre for Consciousness Science, University of Sussex, UK</aff>
<aff id="A5">
<label>5</label>Sussex Partnership NHS Foundation Trust, Brighton, UK</aff>
<author-notes>
<corresp id="FN1">CORRESPONDING AUTHOR: Dr Neil Harrison: Clinical Imaging Sciences Centre, Brighton &amp; Sussex Medical School, University of Sussex, Falmer, BN1 9RR, UK. Phone: +44(0)1273 876657, <email>n.harrison@bsms.ac.uk</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p>
<bold>DISCLOSURES</bold>
</p>
<p>The authors report no biomedical financial interests or potential conflicts of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>18</day>
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>09</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>6</month>
<year>2019</year>
</pub-date>
<volume>3</volume>
<issue>6</issue>
<fpage>514</fpage>
<lpage>524</lpage>
<!--elocation-id from pubmed: 10.1016/j.bpsc.2017.12.011-->
<abstract>
<p id="P2">Despite a historical focus on neurally-mediated interoceptive signaling mechanisms, humoral (and even cellular) signals also play an important role in communicating bodily physiological state to the brain. These signaling pathways can perturb neuronal structure, chemistry and function leading to discrete changes in behavior. They are also increasingly implicated in the pathophysiology of psychiatric disorders. The importance of these humoral signaling pathways is perhaps most powerfully illustrated in the context of infection and inflammation. Here we provide an overview of how immune activation of neural and humoral interoceptive mechanisms interact to mediate discrete changes in brain and behavior and highlight how activation of these pathways at specific points in neural development may predispose to psychiatric disorder. As our mechanistic understanding of these interoceptive pathways continues to emerge it is revealing novel therapeutic targets, potentially heralding an exciting new era of immunotherapies in psychiatry.</p>
</abstract>
<kwd-group>
<kwd>Autism</kwd>
<kwd>Cytokine</kwd>
<kwd>Depression</kwd>
<kwd>fMRI</kwd>
<kwd>Imaging</kwd>
<kwd>Inflammation</kwd>
<kwd>Insula</kwd>
<kwd>Interoception</kwd>
<kwd>Schizophrenia</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>